Mind Medicine (MindMed) (NasdaqGS:MNMD) Stock Forecast & Analyst Predictions - Simply Wall St (2024)

Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely MindMed: Not The Horse To Back If You're Looking To Buy Psychedelics MindMed announces proposed public offering of common shares MindMed doses first patient in phase 1 trial examining psychedelic MDMA-like substances MindMed regains compliance with Nasdaq's minimum bid price listing requirement MindMed: Confusing MEME Rally Hides A Company That Looks Empty Of Value Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans Magic mushrooms psychedelic compound can help with treatment of alcohol use disorder MindMed soars 71% as it appears to be following in Bed Bath & Beyond's footsteps Mind Medicine GAAP EPS of -$0.04 beats by $0.01 Mind Medicine announces 1-for-15 reverse stock split MindMed: Another Psychedelic Medicine Play Trading At A Potential Discount Mind Medicine: It's Best To Stay Far Away From This Risky Psychedelic Stock MindMed: Falling Uncontrollably